About me
Sai Dharmarajan is a Director of Biostatistics at Sarepta Therapeutics. Prior to joining Sarepta he was a Senior Statistical Reviewer at FDA from 2018 to 2023. He is an active member of multiple cross-industry working groups on Real World-Evidence, Benefit-risk and Artificial Intelligence / Machine Learning. His research interests span quantitative benefit-risk, causal inference, survival analysis and anything else his work requires. He obtained his PhD in Biostatistics from University of Michigan in 2018.
